SIGA Technologies — Three and Nine Months Ended September 30, 2026 Earnings Summary
SIGA Technologies reported total revenues of $1.3 million for the three months ended September 30, 2026, and $48.6 million for the nine-month period, compared to $2.6 million and $90.8 million respectively in the prior year periods. The company recorded a net loss of $2.9 million for the quarter and a net income of $6.1 million for the first nine months of 2026. Key operational highlights include a $15 million procurement contract awarded by the Canadian Department of National Defence for oral TPOXX and the fulfillment of the final order under the U.S. Strategic National Stockpile's 19C contract for IV TPOXX. Additionally, the company declared a special cash dividend of $0.60 per share in March 2026 and announced the retirement of its Chief Scientific Officer, Dennis Hrubry.
- Company
- SIGA TECHNOLOGIES INC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic